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Abstract Seven transmembrane domain G-protein-coupled
receptors constitute the largest family of proteins in
mammals. Signal transduction events mediated by such
receptors are the primary means by which cells communi-
cate with and respond to their external environment. The
major paradigm in this signal transduction process is that
stimulation of the receptor leads to the recruitment and
activation of heterotrimeric GTP-binding proteins. These
initial events, which are fundamental to all types of
G-protein-coupled receptor signaling, occur at the plasma
membrane via protein–protein interactions. As a result, the
dynamics of the activated receptor on cell surfaces
represents an important determinant in its encounter with
G-proteins, and has significant impact on the overall
efficiency of the signal transduction process. We have
monitored the cell surface dynamics of the serotonin1A
receptor, an important member of the G-protein-coupled
receptor superfamily, in relation to its interaction with
G-proteins. Fluorescence recovery after photobleaching
experiments carried out with the receptor tagged to the
enhanced yellow fluorescent protein indicate that G-protein
activation alters the diffusion properties of the receptor in a
manner suggesting the activation process leads to dissoci-
ation of G-proteins from the receptor. This result demon-
strates that the cell surface dynamics of the serotonin1A
receptor is modulated in a G-protein-dependent manner.
Importantly, this result could provide the basis for a
sensitive and powerful approach to assess receptor/
G-protein interaction in an intact cellular environment.
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Abbreviations
5-HT1A
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5-hydroxytryptamine-1A receptor
EYFP enhanced yellow fluorescent protein
FRAP fluorescence recovery after photobleaching
GFP green fluorescent protein
GPCR G-protein-coupled receptor
PCR polymerase chain reaction
Introduction
The G-protein-coupled receptor (GPCR)1 superfamily is
one of the largest protein families in mammals and accounts
for >1% of the total proteins coded by the human genome
[1–3]. Cellular signaling by GPCRs involves their activa-
tion upon binding to ligands present in the extracellular
environment and the subsequent transduction of signals to
the interior of the cell through concerted changes in their
transmembrane domain structure [4]. The major paradigm
in this signal transduction process is that stimulation of
GPCRs leads to the recruitment and activation of hetero-
trimeric GTP-binding proteins (G-proteins) [5]. These
initial events, fundamental to all types of GPCR signaling,
occur at the plasma membrane via protein-protein inter-
actions. An important consequence of this is that the
dynamics of the activated receptor on the cell surface
represents an important determinant in its encounter with
G-proteins, and has significant impact on the overall
efficiency of the signal transduction process [6]. In this
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context, the cell surface organization of GPCRs and G-
proteins participating in this signal transduction process
assumes relevance. Recent evidence has indicated that a
spatiotemporally organized system of interacting molecules
rather than a freely diffusible system is responsible for rapid
and specific propagation of extracellular stimuli to intracel-
lular signaling molecules [7, 8]. Based on these and other
results, it has been proposed that GPCRs are not uniformly
present on the plasma membrane but are concentrated in
specific membrane microdomains [9]. This heterogenous
distribution of GPCRs into domains has given rise to new
challenges and complexities in receptor signaling since
signaling now has to be understood in context of the three
dimensional organization of various signaling components
which include receptors and G-proteins.
Serotonin (5-hydroxytryptamine or 5-HT) is an intrinsi-
cally fluorescent neurotransmitter [10] and exerts its actions
by binding to distinct membrane receptors classified into
many groups [11]. Among the 14 subtypes of serotonin
receptors, the G-protein-coupled serotonin1A (5-HT1A)
receptor subtype is the most extensively studied for a
number of reasons [12]. Importantly, the 5-HT1A receptor
levels and function have been shown to be important
indices to diagnose several psychological disorders. These
include alterations in the receptor levels in schizophrenia
[13] and depression [14], polymorphisms in the upstream
repressor region of the 5-HT1A receptor gene in major
depression and suicide in humans [15], and altered receptor
ligand-binding function in panic disorder [16]. The 5-HT1A
receptor has recently been shown to have a role in neural
development [17] and protection of stressed neuronal cells
undergoing degeneration and apoptosis [18]. In addition,
5-HT1A receptor antagonists represent a major class of
molecules with potential therapeutic effects in anxiety- or
stress-related disorders [19]. We have earlier shown
modulation of ligand binding activity of the 5-HT1A
receptor isolated from the bovine hippocampus with agents
that perturb G-proteins [20, 21]. In addition, we have
solubilized and partially purified the 5-HT1A receptor from
both the native bovine hippocampus [22] and heterologously
expressed human 5-HT1A receptors from Chinese hamster
ovary cells [23], where the receptor was found to possess
very similar pharmacological characteristics as in the native
system [24].
Monitoring diffusion of cell surface molecules represents
a powerful approach to detect their organization on the
plasma membrane [25, 26]. In the light of the proposed
significance of a spatiotemporally restricted environment
in modulating receptor and G-protein interaction (see
above), we have utilized the previously characterized
serotonin1A receptor tagged to the enhanced yellow
fluorescence protein (EYFP) [27] to analyze its cell surface
dynamics (diffusion properties) using the technique of
fluorescence recovery after photobleaching (FRAP) [28,
29]. Based on the analysis of FRAP data, we provide
evidence that cell surface dynamics of this receptor is altered
upon receptor independent activation of G-proteins in an
intact cellular environment. These results provide novel
information on signaling events involving the 5-HT1A
receptor in cells and suggest that the association of G-
proteins with the 5-HT1A receptor could be an important
determinant in its spatiotemporal organization on the cell
surface.
Materials and methods
Materials
Penicillin, streptomycin, gentamycin sulfate, mastoparan,
and pertussis toxin were obtained from Sigma (St. Louis,
MO). D-MEM/F-12 (Dulbecco’s Modified Eagle Medium:
nutrient mixture F-12 (Ham) (1:1)), lipofectamine, fetal calf
serum, and geneticin (G 418) were from Invitrogen Life
Technologies (Carlsbad, CA). All other chemicals used
were of the highest available purity. Water was purified
through a Millipore (Bedford, MA) Milli-Q system and
used throughout.
Construction of the vector for EYFP-tagged 5-HT1A
receptor and isolation of stable transfectants
The vector coding for the human 5-HT1A receptor tagged at
the C-terminal end to EYFP was used to transfect CHO–K1
cells. The construction of the vector, transfection of CHO–K1
cells, and isolation of transfectants stably expressing the
fusion protein were carried out as described earlier [27].
Confocal microscopy and fluorescence recovery
after photobleaching (FRAP)
Cells were plated at a density of 5×104 cells on a 40 mm
glass coverslip and were grown in D-MEM/F-12 medium
for 72 h. Coverslips were washed with HEPES-Hanks,
pH 7.4 buffer and mounted on an FCS2 closed temperature-
controlled Bioptechs chamber (Butler, PA). Cells were
either treated with AlF4
−(50 μM AlCl3 and 30 mM NaF)
or with 10 μM mastoparan prepared in HEPES-Hanks,
pH 7.4 buffer for 5 to 10 min, or were grown in presence of
pertussis toxin (200 ng/ml) for 24 h before experiments.
Confocal microscopy was carried out using an inverted Zeiss
LSM 510 Meta confocal microscope (Jena, Germany), with
a 63×, 1.2 NAwater-immersion objective using the 514 nm
line of an argon laser as the excitation source. Fluorescence
emission was collected using the 535–590 nm band pass
filter. All images were acquired with the confocal pinhole set
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between 1 and 2 Airy units and an 8-bit, 512×512-pixel
resolution. Fluorescence recovery after photobleaching
(FRAP) experiments were carried out after the FCS2 stage
reached 37°C which took ∼5 min. The uniformly fluorescent
surface of well spread CHO–K1 cells stably expressing 5-
HT1AR-EYFP in contact with the glass coverslip was
imaged for bleaching and monitoring fluorescence recov-
ery. In a typical experiment, a square region of interest
(ROI) of 14 μm length was scanned. Another circular ROI
of 1.4 μm radius was chosen as the bleach ROI within this
square ROI. The time interval between successive scans
was ∼0.63 sec. Analysis with a control ROI drawn a fair
distance away from the bleach ROI indicated no significant
bleach while fluorescence recovery was monitored. Data
representing the mean fluorescence intensity of the
bleached ROI were background subtracted using an ROI
placed outside the cell boundary and were analyzed to
determine the diffusion coefficient (D). FRAP recovery
plots were analyzed based on the equation for a uniform
disk illumination condition [30]:
F tð Þ ¼ F 1ð Þ  F 0ð Þ½  exp 2τd=tð Þ I0 2τd=tð Þ þ I1 2τd=tð Þð Þ½ þF 0ð Þ
ð1Þ
where F(t) is the mean background corrected and normal-
ized fluorescence intensity at time t in the bleached ROI, F
(∞) is the recovered fluorescence at time t = ∞, F(0) is the
bleached fluorescence intensity estimated at time t= 0 and
Cd is the characteristic diffusion time. I0 and I1 are modified
Bessel functions. Diffusion coefficient (D) is determined
from the equation:
D ¼ w2=4td ð2Þ
where ω is the actual radius of the bleached ROI. Mobile
fraction estimates of the fluorescence recovery were
obtained from the equation:
Mobile fraction ¼ F 1ð Þ  F 0ð Þ½ = F pð Þ  F 0ð Þ½  ð3Þ
where F(p) is the mean background corrected and normal-
ized prebleach fluorescence intensity. Non-linear curve
fitting of the recovery data to Eq. (1) was carried out using
the Graphpad Prism software version 4.00 (San Diego,
CA). Significance levels were estimated by one-way
ANOVA using Microcal Origin software version 5.0
(OriginLab Corporation, Northampton, MA).
Results
Fluorescence recovery after photobleaching involves gen-
erating a concentration gradient of fluorescent molecules by
irreversibly photobleaching a fraction of fluorophores in the
sample region [28, 29]. The dissipation of this gradient with
Fig. 1 Fluorescence recovery
after photobleaching 5-HT1A
receptor tagged to EYFP in
CHO–K1 cells. Fluorescence
images of cells were acquired at
37°C and represent confocal
sections of the base of the cells.
Images of the same cell in
panels (a), (b), (c), and (d)
show fluorescence intensity
before and after bleaching for
the indicated duration of time.
The prebleach images/intensi-
ties are shown at time t < 0 and
the bleach event is shown at
time t = 0. The normalized
fluorescence intensity in Re-
gion 1 calculated from these
images is plotted in panel (e).
The fluorescence intensity in
the control Region 2 monitored
for the same time period and
plotted in panel (e) indicates no
significant photobleaching of
the field due to repeated imag-
ing. The fluorescence in Region
1 in panel (e) is fitted to Eq. 1
to arrive at the characteristic
diffusion time τd. Scale bar
represents 5 μm. See Materials
and methods for other details
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time owing to diffusion of fluorophores into the bleached
region from the unbleached regions in the membrane is an
indicator of the mobility of the fluorophores in the
membrane. A representative panel of images demonstrating
the recovery of fluorescence after photobleaching carried out
on CHO-K1 cells stably expressing the 5-HT1A receptor
tagged to EYFP is shown in Fig. 1. The plots in Fig. 1e
indicate the normalized fluorescence intensity in the bleach
ROI (Region 1) and control ROI (Region 2) monitored for
the entire duration (∼47 sec) of the FRAP experiment. The
parameters for scanning were optimized to ensure that no
significant fluorescence photobleaching occurs due to
repeated imaging. This is indicated by the relatively constant
mean fluorescence intensity in the control ROI (Region 2;
Fig. 1e) during the entire duration of the experiment. Curve
fitting analysis of the FRAP recovery plots from control
cells indicate a mean diffusion coefficient (D) of
∼0.077 μm2 sec−1 (Fig. 2a) and a mobile fraction of
∼80% (Fig. 2b) for the 5-HT1A receptor tagged to EYFP at
37°C. Importantly, a similar analysis of diffusion rates of
pure GFP in 90% glycerol–water mixture at 25°C gave a
mean D of ∼0.65 μm2 sec−1 (T.J. Pucadyil and A.
Chattopadhyay, unpublished observations) which is similar
to the value of 0.7 μm2 sec−1 calculated for GFP using the
Stokes-Einstein equation in a medium of viscosity
corresponding to 90% glycerol-water mixture [31] thus
validating our method of analysis.
To determine the dependence of receptor/G-protein inter-
action on the dynamics of the 5-HT1A receptor, FRAP
experiments were carried out on cells stably expressing the
5-HT1A receptor tagged to EYFP in presence of agents that
either activate G-proteins or covalently modify them to
disrupt their interaction with the receptor. The cationic
peptide mastoparan has been shown to catalyze Gi/o-protein
activation in a manner similar to that mediated by GPCRs
[32]. Treatment of cells with mastoparan increases the
diffusion of the receptor to ~0.092 μm2 sec−1 (Fig. 2a) with
a mobile fraction of ~84% (Fig. 2b). It has been proposed
that AlF4
− mimics the γ-phosphate of GTP in the guanine
nucleotide binding site of GDP bound Gα subunit [33] and
that it can mimic the effects of GTP and GTP-γ-S on G-
proteins. Moreover, cell membranes are permeable to AlF4
−,
unlike GTP or GTP-γ-S, and thus are widely used to activate
G-proteins in intact cells [34]. Treatment of cells with AlF4
−
(50 μM AlCl3+30 mM NaF) significantly increased the
mobility of the receptor (~1.5 fold) to ~0.116 μm2 sec−1
(Fig. 2a) with a mobile fraction of ~85% (Fig. 2b). Taken
together, these results suggest that the activation of G-
proteins significantly increases the cell surface mobility of
the 5-HT1A receptor tagged to EYFP. This increase could be
due to the dissociation of G-proteins from the receptor due to
activation of G-proteins. If this were true, then prevention of
receptor and G-protein interaction per se should also lead to
an increase in receptor diffusion. To achieve this, cells were
treated with pertussis toxin, which ADP-ribosylates and
inactivates the α subunit of Gi/o class of G-proteins [35].
Importantly, FRAP experiments carried out on cells treated
with pertussis toxin indicate an increase in mobility of the
receptor to ~0.097 μm2 sec−1 (Fig. 2a) with a mobile
fraction of ~83% (Fig. 2b) thus supporting our interpretation
on the increase in receptor diffusion in the presence of the
activators of G-proteins.
Discussion
We have earlier reported the pharmacological and cellular
signaling characteristics of the 5-HT1A receptor tagged to
Fig. 2 G-protein-dependent diffusion characteristics of the 5-HT1A
receptor tagged to EYFP in CHO-K1 cells. (a) Diffusion coefficients
of the 5-HT1A receptor tagged to EYFP are shown under normal
conditions (control) and in presence of mastoparan (10 μM),
AlF4
−(50 μM AlCl3+30 mM NaF) and when cells are grown in the
presence of pertussis toxin (200 ng/ml). (b) Mobile fractions of the
5-HT1A receptor tagged to EYFP are shown under the same
conditions. The data represent the means ± standard error of at least
11 independent experiments for each condition. The means are
significantly different from control values at P < 0.05 (*), and P <
0.005 (#). Data in panel (a) is adapted from Ref. [27]. See Materials
and methods for other details
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EYFP at its carboxy terminus and stably expressed in
CHO-K1 cells [27]. Thus, binding affinities of the specific
agonist 8-OH-DPAT and antagonist p-MPPF and extents of
receptor/G-protein interaction were found to be similar
between the tagged and untagged forms of 5-HT1A receptor.
Importantly, the natural agonist serotonin can efficiently
catalyze downstream signal transduction events in cells
expressing the 5-HT1A receptor tagged to EYFP by
reducing the forskolin-stimulated cAMP levels in these
cells. These results suggest that the tagged form of the
receptor can be reliably used to mimic native 5-HT1A
receptors to explore cell surface organization, distribution
and dynamics using fluorescence approaches.
The analysis of cell surface dynamics of membrane
proteins such as GPCRs is crucial for a comprehensive
understanding of their organization and signaling functions.
Since G-proteins are, by themselves, membrane anchored
proteins, it is evident that cell surface dynamics of both the
receptor and G-protein are important determinants of G-
protein-coupled signal transduction events. In this report, we
have utilized the EYFP fluorescence to monitor the
dynamics of the receptor on the cell surface under conditions
of G-protein activation/covalent modification using the
technique of FRAP. The observed increase in the diffusion
of the receptor upon activation of G-proteins with masto-
paran and AlF4
− suggest that the association of G-proteins
with the receptor tends to reduce its lateral mobility on the
cell surface. Treatment of cells with pertussis toxin that
reduces receptor and G-protein interaction also causes an
increase in receptor diffusion, thus providing further
evidence to support this interpretation. The G-protein
heterotrimer is a large protein complex with an average
molecular weight of ∼88 kDa [36], which would be ∼1.2
times the mass of the receptor tagged to EYFP. It is,
therefore, possible that their association with the receptor
would reduce its diffusion coefficient. Models on G-protein
action indicate the activation process stimulates the ex-
change of a GTP for the existing GDP molecule at the Gα
subunit [36]. When this occurs, the receptor-bound G-
protein heterotrimer complex dissociates until another
inactive G-protein binds to the receptor. Independent
activation of G-proteins with mastoparan would tend to
keep the receptor dissociated from G-proteins. The presence
of AlF4
− would lock the Gα subunits in an active state,
similar to a GTP-γ-S-bound Gα subunit, preventing them
from associating with the receptor [33, 34] and thereby
increasing the fraction of receptors uncoupled to G-
proteins. The treatment of cells with pertussis toxin would
inactivate the existing pool of G-proteins and increase the
fraction of receptors uncoupled to G-proteins [35]. A recent
fluorescence correlation spectroscopy study carried out on
rhodamine-labeled galanin bound to galanin receptors
supports this possibility [37]. Analysis of the diffusion
properties of galanin receptor detected the presence of at
least two populations of the receptor. Treatment of cells
with pertussis toxin to inactivate endogenous G-proteins led
to a complete loss of the slowly diffusing population which
was due to receptors coupled to G-proteins [37].
Diffusion behavior of several integral membrane pro-
teins indicate that the cytoskeleton underlying the cell
surface can act as a barrier to free diffusion of these
proteins. This is thought to occur due to the steric hindrance
imposed by the cytoskeleton on the cytoplasmic domains of
these proteins. Treatment of cells with agents that disrupt
the cytoskeleton [38], truncation of the cytoplasmic
domains of transmembrane proteins [39], or a lack of
interaction of membrane proteins with cytoplasmic effector
molecules [40] tends to increase their mobility on the cell
surface. Likewise, the presence of the bulky heterotrimeric
G-protein complex associated with the receptor (since G-
proteins, when bound to membrane receptors, could be
considered as equivalent to cytoplasmic domains of
membrane proteins) could further reduce (over the differ-
ences arising due to molecular mass of G-proteins) receptor
diffusion, which would be partially relieved when the G-
protein dissociates from the receptor. Another possibility
could be that the increase in receptor diffusion could reflect
changes in the oligomeric state of the receptor, as has been
shown for the δ-opioid receptor [41], and the cholecysto-
kinin receptor [42] or their partitioning into or out of
domains proposed to exist on the cell surface [7, 9].
Incidentally, there is growing evidence on the compartmen-
talized localization of G-proteins in cholesterol-rich mem-
brane domains [43] that have been reported to diffuse as
separate entities on the membrane [44]. Whether the
differences in the diffusion properties of the receptor while
being associated with or without G-proteins results from the
movement of receptors into or out of such domains
represents an interesting possibility.
In summary, we conclude that the cell surface dynamics
of the 5-HT1A receptor is modulated in a G-protein
dependent manner. Our results on the G-protein dependent
cell surface dynamics of the 5-HT1A receptor provide novel
insight and present a sensitive and powerful approach to
assess receptor/G-protein interaction in an intact cellular
environment. This approach could prove to be useful in
analyzing molecular mechanism of signal transduction of
5-HT1A receptors in particular and G-protein-coupled
receptors in general.
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